A Trial to Learn More About an Experimental Gene Therapy Called Bidridistrogene Xeboparvovec (SRP-9003) as a Possible Treatment for Limb Girdle Muscular Dystrophy 2E/R4 (EMERGENE)

Limb-girdle Muscular Dystrophy Clinical Trial

Official title:
A Phase 3 Multinational, Open-label, Systemic Gene Delivery Study to Evaluate the Safety and Efficacy of SRP-9003 in Subjects With Limb Girdle Muscular Dystrophy 2E/R4

Status Recruiting

Clinical Trial Summary

This is a multicenter, global study of the effects of a single systemic dose of SRP-9003 on beta-sarcoglycan (β-SG) gene expression in participants with limb-girdle muscular dystrophy, type 2E/R4 (LGMD2E/R4). This study will consist of both ambulatory participants (Cohort 1) and non-ambulatory participants (Cohort 2).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06246513
Study type	Interventional
Source	Sarepta Therapeutics, Inc.
Contact	Sarepta Therapeutics Inc. For Clinical Trial Information, Select
Phone	1-888-SAREPTA (1-888-727-3782)
Email	SareptAlly@sarepta.com
Status	Recruiting
Phase	Phase 3
Start date	January 15, 2024
Completion date	November 30, 2029

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT01403402` - Congenital Muscle Disease Study of Patient and Family Reported Medical Information
Terminated	`NCT03783923` - A Study of Deflazacort (Emflaza®) in Participants With Limb-Girdle Muscular Dystrophy 2I (LGMD2I)	Phase 3
Completed	`NCT02635321` - MRI and Muscle Involvement in Patients With Mutations in GMPPB	N/A
Completed	`NCT00873782` - Safety Study of Transvenous Limb Perfusion in Human Muscular Dystrophy	Phase 1
Completed	`NCT00457912` - Genetic Characterization of Individuals With Limb Girdle Muscular Dystrophy	N/A
Not yet recruiting	`NCT06399770` - The Role of Muscle Ultrasound in Assessment of Sample of Patients With Limb-girdle Muscular Dystrophy
Completed	`NCT04054375` - Weekly Steroids in Muscular Dystrophy	Phase 2
Recruiting	`NCT00390104` - Molecular Analysis of Patients With Neuromuscular Disease
Completed	`NCT00104078` - Study Evaluating MYO-029 in Adult Muscular Dystrophy	Phase 1/Phase 2
Recruiting	`NCT04475926` - A Study of the Natural History of Participants With LGMD2E/R4, LGMD2D/R3, LGMD2C/R5, and LGMD2A/R1 ≥ 4 Years of Age, Who Are Managed in Routine Clinical Practice
Completed	`NCT02759302` - MRI on Persons With Mutations in POMT2 Gene (LGMD2N)	N/A